Global Cystic Fibrosis Therapeutics Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Instruments
    • 2.1.1.1. Secondary Instrument
    • 2.1.1.2. Primary Instrument
  • 2.1.2. Research Approaches
    • 2.1.2.1. Bottom-up Approach
    • 2.1.2.2. Top-down Approach
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
  • 2.1.5. Vendor Inclusion Criteria
• 2.2. Forecasting Methodology
  • 2.2.1. Methodology for Market Estimation & Forecasting
  • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight

• 4.1. Market Connectivity
• 4.2. Market Data Feed
• 4.3. Market Vendor Ranking Analysis
• 4.4. Market Dynamics
  • 4.4.1. Drivers
    • 4.4.1.1. Improved diagnostic technologies
    • 4.4.1.2. Rising prevalence of Cystic Fibrosis
    • 4.4.1.3. Increasing global awareness for Cystic Fibrosis
    • 4.4.1.4. Research & development activities
    • 4.4.1.5. Robust drug development pipeline
    • 4.4.1.6. Favorable initiatives taken by NGOs, government, and private companies
  • 4.4.2. Restraints
    • 4.4.2.1. Expiring patents and generic drugs
    • 4.4.2.2. Increase in genetic mutation rate
  • 4.4.3. Opportunities
    • 4.4.3.1. Increasing demand from emerging economies
    • 4.4.3.2. Growing strategic collaborations and Merger & Acquisition
  • 4.4.4. Challenges
    • 4.4.4.1. High cost involved in treatment and complicated pathophysiology
• 4.5. Porter’s Five Forces Analysis
  • 4.5.1. Threat of New Entrants
  • 4.5.2. Threat of Substitutes
  • 4.5.3. Bargaining Power of Customers
  • 4.5.4. Bargaining Power of Suppliers
  • 4.5.5. Industry Rivalry
• 4.6. Advances in Technology for Drug Development and Delivery

5. Global Cystic Fibrosis Therapeutics Market, by Drug Class

• 5.1. Introduction
• 5.2. Anti-Infectives
• 5.3. Bronchodilators
• 5.4. CFTR Modulators
• 5.5. Mucolytics
• 5.6. PERT

6. Global Cystic Fibrosis Therapeutics Market, by Type

• 6.1. Introduction
• 6.2. Inhaled Drugs
• 6.3. Oral Drugs

7. Global Cystic Fibrosis Therapeutics Market, by Geography

• 7.1. Introduction
• 7.2. Americas Cystic Fibrosis Therapeutics Market
  • 7.2.1. Americas Cystic Fibrosis Therapeutics Market, by Country
    • 7.2.1.1. United States
    • 7.2.1.2. Brazil
    • 7.2.1.3. Canada
    • 7.2.1.4. Mexico
    • 7.2.1.5. Argentina
  • 7.2.2. Americas Cystic Fibrosis Therapeutics Market, by Drug Class
  • 7.2.3. Americas Cystic Fibrosis Therapeutics Market, by Type
• 7.3. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market
  • 7.3.1. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Country
    • 7.3.1.1. United Kingdom
    • 7.3.1.2. Germany
    • 7.3.1.3. France
    • 7.3.1.4. Saudi Arabia
    • 7.3.1.5. United Arab Emirates
    • 7.3.1.6. Italy
    • 7.3.1.7. Russia
  • 7.3.2. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Drug Class
  • 7.3.3. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Type
• 7.4. Asia-Pacific Cystic Fibrosis Therapeutics Market
  • 7.4.1. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Country
    • 7.4.1.1. China
    • 7.4.1.2. Japan
    • 7.4.1.3. India
    • 7.4.1.4. Australia
  • 7.4.2. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Drug Class
  • 7.4.3. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Type

8. Competitive Strategic Window

• 8.1. Introduction
  • 8.1.1. Leverage Zone
  • 8.1.2. Vantage Zone
  • 8.1.3. Speculative Zone
  • 8.1.4. Bottleneck Zone

9. FPNV Positioning Matrix

• 9.1. Introduction
• 9.2. Scores
  • 9.2.1. Forefront
  • 9.2.2. Pathfinders
  • 9.2.3. Niche
  • 9.2.4. Vital
• 9.3. Business Strategy
• 9.4. Product Satisfaction

10. Competitive News Feed Analysis

11. Company Usability Profiles

• 11.1. AbbVie Inc.
• 11.2. Alaxia
• 11.3. Alcresta Therapeutics, Inc.
• 11.4. Allergan plc
• 11.5. AstraZeneca PLC
• 11.6. Chiesi Pharmaceuticals B.V.
• 11.7. F. Hoffmann-La Roche Ltd
• 11.8. Genentech, Inc.
• 11.9. Gilead Sciences, Inc.
• 11.10. Merck & Co., Inc.
• 11.11. Novartis International AG
• 11.12. Pharmaxis Ltd
• 11.13. Teva Pharmaceutical Industries Limited
• 11.14. Vertex Pharmaceuticals Incorporated

12. Appendix

• 12.1. Top Reports
• 12.2. Author Details

LIST OF TABLES (27 TABLES)

TABLE 1. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 2. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET RANKING, BY VENDORS, 2017

TABLE 3. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

TABLE 4. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 5. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 6. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 7. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 8. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY PERT, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 9. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 10. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 11. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 12. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 13. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 14. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

TABLE 15. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 16. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 17. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

TABLE 18. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 19. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 20. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

TABLE 21. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 22. 360IRESEARCH SCORES FOR FOREFRONT IN CYSTIC FIBROSIS THERAPEUTICS MARKET

TABLE 23. 360IRESEARCH SCORES FOR PATHFINDERS IN CYSTIC FIBROSIS THERAPEUTICS MARKET

TABLE 24. 360IRESEARCH SCORES FOR NICHE IN CYSTIC FIBROSIS THERAPEUTICS MARKET

TABLE 25. 360IRESEARCH SCORES FOR VITAL IN CYSTIC FIBROSIS THERAPEUTICS MARKET

TABLE 26. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR CYSTIC FIBROSIS THERAPEUTICS MARKET

TABLE 27. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR CYSTIC FIBROSIS THERAPEUTICS MARKET

LIST OF FIGURES (25 TABLES)

FIGURE 1. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: YEARS CONSIDERED FOR THE STUDY

FIGURE 2. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH METHODOLOGY

FIGURE 3. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH INSTRUMENTS

FIGURE 4. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES

FIGURE 5. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY POTENTIAL RESPONDENTS

FIGURE 6. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

FIGURE 7. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH APPROACHES

FIGURE 8. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY DATA TRIANGULATION

FIGURE 9. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH ASSUMPTIONS

FIGURE 10. CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY MARKET CONNECTIVITY

FIGURE 11. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

FIGURE 12. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017 VS 2024 (USD BILLION)

FIGURE 13. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 14. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 15. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 16. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 17. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY PERT, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 18. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD BILLION)

FIGURE 19. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 20. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 21. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)

FIGURE 22. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY DRUG CLASS, 2024

FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY TYPE, 2024

FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY GEOGRAPHY, 2024

FIGURE 25. 360IRESEARCH FPNV POSITIONING MATRIX FOR CYSTIC FIBROSIS THERAPEUTICS MARKET